These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 28086164)

  • 1. Lacosamide for uncontrolled primary generalized tonic-clonic seizures: An open-label pilot study with 59-week extension.
    Wechsler RT; Yates SL; Messenheimer J; Leroy R; Beller C; Doty P
    Epilepsy Res; 2017 Feb; 130():13-20. PubMed ID: 28086164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials.
    Biton V; Gil-Nagel A; Isojarvi J; Doty P; Hebert D; Fountain NB
    Epilepsy Behav; 2015 Nov; 52(Pt A):119-27. PubMed ID: 26414341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of lacosamide as first add-on or later adjunctive treatment for uncontrolled partial-onset seizures: A multicentre open-label trial.
    Zadeh WW; Escartin A; Byrnes W; Tennigkeit F; Borghs S; Li T; Dedeken P; De Backer M;
    Seizure; 2015 Sep; 31():72-9. PubMed ID: 26362380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, tolerability, and efficacy of adjunctive lacosamide in pediatric patients with epilepsy syndromes associated with generalized seizures: Phase 2, open-label exploratory trial.
    Auvin S; Arzimanoglou A; Beller C; Floricel F; Daniels T; Bozorg A
    Epilepsia; 2023 Nov; 64(11):2947-2957. PubMed ID: 37545406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive lacosamide for focal epilepsy: an open-label trial evaluating the impact of flexible titration and dosing on safety and seizure outcomes.
    Baulac M; Coulbaut S; Doty P; McShea C; De Backer M; Bartolomei F; Vlaicu M
    Epileptic Disord; 2017 Jun; 19(2):186-194. PubMed ID: 28597842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial.
    Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P
    Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of adjunctive lacosamide for the treatment of partial-onset seizures in Chinese and Japanese adults: A randomized, double-blind, placebo-controlled study.
    Hong Z; Inoue Y; Liao W; Meng H; Wang X; Wang W; Zhou L; Zhang L; Du X; Tennigkeit F;
    Epilepsy Res; 2016 Nov; 127():267-275. PubMed ID: 27669155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.
    Delanty N; Jones J; Tonner F
    Epilepsia; 2012 Jan; 53(1):111-9. PubMed ID: 22050371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study.
    Runge U; Arnold S; Brandt C; Reinhardt F; Kühn F; Isensee K; Ramirez F; Dedeken P; Lauterbach T; Noack-Rink M; Mayer T
    Epilepsia; 2015 Dec; 56(12):1921-30. PubMed ID: 26526971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A long-term noninterventional safety study of adjunctive lacosamide therapy in patients with epilepsy and uncontrolled partial-onset seizures.
    Steinhoff BJ; Eckhardt K; Doty P; De Backer M; Brunnert M; Schulze-Bonhage A
    Epilepsy Behav; 2016 May; 58():35-43. PubMed ID: 27054272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year efficacy of lacosamide as adjunctive therapy for generalized tonic-clonic seizures in patients with juvenile myoclonic epilepsy.
    Kobayashi Y; Honda R; Yamada K; Hojo M; Miura M; Seki E; Ono T; Tohyama J
    Brain Dev; 2023 Sep; 45(8):451-455. PubMed ID: 37308336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and tolerability of adjunctive lacosamide intravenous loading dose in lacosamide-naive patients with partial-onset seizures.
    Fountain NB; Krauss G; Isojarvi J; Dilley D; Doty P; Rudd GD
    Epilepsia; 2013 Jan; 54(1):58-65. PubMed ID: 22708895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open-label extension trial of up to 8 years.
    Rosenfeld W; Fountain NB; Kaubrys G; Ben-Menachem E; McShea C; Isojarvi J; Doty P;
    Epilepsy Behav; 2014 Dec; 41():164-70. PubMed ID: 25461210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and tolerability of short-term infusions of intravenous lacosamide in pediatric patients with epilepsy: An open-label, phase 2/3 trial.
    Farkas MK; Beller C; Bozorg A; McClung C; Roebling R; Yates T; Yuen N; Makedonska I
    Epilepsia Open; 2023 Mar; 8(1):146-153. PubMed ID: 36529709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial.
    Vossler DG; Knake S; O'Brien TJ; Watanabe M; Brock M; Steiniger-Brach B; Williams P; Roebling R;
    J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1067-1075. PubMed ID: 32817358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy, safety, and tolerability, including behavior and executive functioning, during adjunctive lacosamide treatment in pediatric patients with uncontrolled epilepsy.
    Farkas MK; Makedonska I; Beller C; Bourikas D; de la Loge C; Dimova S; Floricel F; McClung C; Moseley B; Therriault S; Pina-Garza JE
    Epilepsy Behav; 2024 Oct; 159():109989. PubMed ID: 39216464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugs.
    Sake JK; Hebert D; Isojärvi J; Doty P; De Backer M; Davies K; Eggert-Formella A; Zackheim J
    CNS Drugs; 2010 Dec; 24(12):1055-68. PubMed ID: 21090839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term exposure and safety of lacosamide monotherapy for the treatment of partial-onset (focal) seizures: Results from a multicenter, open-label trial.
    Vossler DG; Wechsler RT; Williams P; Byrnes W; Therriault S;
    Epilepsia; 2016 Oct; 57(10):1625-1633. PubMed ID: 27528101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive perampanel and myoclonic and absence seizures: Post hoc analysis of data from study 332 in patients with idiopathic generalized epilepsy.
    Brandt C; Wechsler RT; O'Brien TJ; Patten A; Malhotra M; Ngo LY; Steinhoff BJ
    Seizure; 2020 Aug; 80():115-123. PubMed ID: 32563171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.